0001127602-23-018786.txt : 20230615 0001127602-23-018786.hdr.sgml : 20230615 20230615163906 ACCESSION NUMBER: 0001127602-23-018786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASELAGE STEVE CENTRAL INDEX KEY: 0001221599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 231017952 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-06-13 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001221599 ASELAGE STEVE 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 1 0 Common Stock 2023-06-13 4 A 0 16745 0 A 63339 D Automatic Stock Option Grant 8.18 2023-06-13 4 A 0 39072 0 A 2024-06-13 2033-06-13 Common Stock 39072 39072 D Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. /s/ Alane P. Barnes, by power of attorney 2023-06-15